ALG9 |
Last Update:2016-08-10 |
ALG9 encodes alpha-1,2-mannosyltransferase that is involved in the synthesis of lipid-linked oligosaccharides in the endoplasmic reticulum. Dolichol-phosphate-mannose is used for the donor substrate. ALG9 complements the defect of the yeast alg9 mutant. Mutation of ALG9 is associated with congenital disorder of glycosylation type 1L.
|
||
JCGG-STR000132
GlyTouCan:
G44865OQ
GlyCosmos Glycans:
G44865OQ
|
JCGG-STR000133
GlyTouCan:
G72103RY
GlyCosmos Glycans:
G72103RY
|
|
||
JCGG-STR000134
GlyTouCan:
G48148JS
GlyCosmos Glycans:
G48148JS
|
JCGG-STR028843
GlyTouCan:
G39578OU
GlyCosmos Glycans:
G39578OU
|
ALG9 Alias | |
Designation | Dol-P-Mannose:Man6GlcNAc2-PP-dolichol alpha-1,2-mannosyltransferase, Dol-P-Mannose:Man8GlcNAc2-PP-dolichol alpha-1,2-mannosyltransferase |
Organism | Homo sapiens |
GeneID | 79796 |
HGNC | ALG9 (15672) |
mRNA | NM_024740 |
map | 11q22-23 |
Protein | NP_079016 |
EC# | |
CAZy | |
GlyCosmos Glycogenes | ALG9 |
OMIM | 606941 |
CDG Il , Congenital Disorder of Glycosylation type Il | |
GDGDB | CON00354 |
Human Protein Atlas | ENSG00000086848 |
data available from v22.proteinatlas.org